327 related articles for article (PubMed ID: 10481590)
1. [Anti-HB-core antibodies as a surrogate marker in blood donors].
Blejer JL; Saguier MC; Salamone HJ
Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
[No Abstract] [Full Text] [Related]
2. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
4. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
Gavilán Carrasco JC; González Santos P; Rosario Díaz E
Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
[TBL] [Abstract][Full Text] [Related]
6. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
[TBL] [Abstract][Full Text] [Related]
7. Relative safety of first-time volunteer and replacement donors in West Africa.
Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008.
Khattab MA; Eslam M; Sharwae MA; Hamdy L
Am J Infect Control; 2010 Oct; 38(8):640-1. PubMed ID: 20400204
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of markers for human immunodeficiency, hepatitis B and hepatitis C viruses in maxillofacial and oral surgery patients at Medunsa.
Dreyer AF; Aspinall S; Jacobs FJ
J Dent Assoc S Afr; 1993 Jul; 48(7):377-80. PubMed ID: 9511617
[TBL] [Abstract][Full Text] [Related]
10. [Screening for markers of blood-borne diseases in donated units collected in France from 1993 to 1995].
Saura C; Pillonel J; Couroucé AM
Transfus Clin Biol; 1997 Jul; 4(4):403-15. PubMed ID: 9333419
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B and C in Egypt and Africa.
Attia MA
Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
13. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].
Dray X; Dray-Spira R; Bronstein JA; Mattera D
Med Trop (Mars); 2005; 65(1):39-42. PubMed ID: 15903075
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
15. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
16. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
Busch MP
Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
[No Abstract] [Full Text] [Related]
17. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
[No Abstract] [Full Text] [Related]
18. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
[TBL] [Abstract][Full Text] [Related]
20. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses.
Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP
J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
